-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
-
Summary
-
Allogene Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q4 2017 to Q1 2025.
- Allogene Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $99K, a 1138% increase year-over-year.
- Allogene Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $694K, a 54.2% decline from 2023.
- Allogene Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1.52M, a 70.8% decline from 2022.
- Allogene Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $5.19M, a 75.8% decline from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)